Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 27;22(1):768.
doi: 10.1186/s12864-021-07880-z.

circ_0038718 promotes colon cancer cell malignant progression via the miR-195-5p/Axin2 signaling axis and also effect Wnt/β-catenin signal pathway

Affiliations

circ_0038718 promotes colon cancer cell malignant progression via the miR-195-5p/Axin2 signaling axis and also effect Wnt/β-catenin signal pathway

Haitao Gu et al. BMC Genomics. .

Abstract

Objective: Colon cancer (CC) is one of the most common cancers whose progression is regulated by a number of factors, including circular RNAs (circRNAs). Nonetheless, circ_0038718 is a novel circRNA, and its regulatory mechanism in CC remains unclear.

Methods: Real-time quantitative PCR (qRT-PCR) was performed to detect the expression of circ_0038718, miR-195-5p and Axin2. Western blot was conducted to determine the protein expression of Axin2 and the key proteins on Wnt/β-catenin signaling pathway. Oligo (dT) 18 primers and RNase R were employed to identify the circular features of circ_0038718, and the location of circ_0038718 in cells was detected via nucleocytoplasmic separation. Dual-luciferase reporter assay and RNA binding protein immunoprecipitation experiment were carried out to investigate the molecular mechanism of circ_0038718/miR-195-5p/Axin2. Additionally, MTT assay was conducted to assess cell proliferation; Transwell assay was performed to evaluate cell migration and invasion, respectively. The effect of circ_0038718 on CC tumor growth was tested through tumor formation in nude mice.

Results: circ_0038718 was highly expressed in CC and could sponge miR-195-5p in cytoplasm. Silencing circ_0038718 suppressed the proliferative, migratory and invasive abilities of CC cells, while the promoting effect of high circ_0038718 expression on CC cells was reversed upon miR-195-5p over-expression. Axin2 was a downstream target of miR-195-5p and could regulate the Wnt/β-catenin signaling pathway. Axin2 expression was modulated by circ_0038718/miR-195-5p. Knockdown of Axin2 could also attenuate the promoting effect of high circ_0038718 expression on CC cell malignant progression, thus inhibiting tumor growth.

Conclusion: circ_0038718 is able to facilitate CC cell malignant progression via the miR-195-5p/Axin2 axis, which will provide a new idea for finding a novel targeted treatment of CC.

Keywords: Invasion; Migration; Proliferation; Wnt/β-catenin signaling pathway; circ_0038718; colon cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
circ_0038718 is up-regulated in CC tissue and cells. (A) 59 DE_circRNAs obtained from GSE126094 (circRNA) Series Matrix File; (B) Relative expression of circ_0038718 in the GEO database (Blue and red boxes represent normal and tumor group, respectively); (C) Expression of circ_0038718 in adjacent tissue and colorectal cancer tissue, respectively; (D) qRT-PCR was performed to detect circ_0038718 expression in normal human colon cell line CCD-18Co and CC cell lines LoVo, HT-29, HCT116 and SW480; (E) Relative expression of circ_0038718 and mIL4R in HT-29 and SW480 cells were analyzed by qRT-PCR after normalized with random primers and oligo (dT) 18 primers; (F) Relative expression of circ_0038718 and mIL4R in HT-29 and SW480 cells were assessed via qRT-PCR after treatment with RNase R. * p < 0.05
Fig. 2
Fig. 2
circ_0038718 promotes CC cell proliferation, migration and invasion. (A) qRT-PCR was performed to detect circ_0038718 expression in all groups; (B) MTT assay was conducted to assess the viability and proliferative ability of CC cells in all groups; (C-D) Transwell assay was carried out to evaluate CC cell migratory and invasive capacities in all groups (100×). * p < 0.05
Fig. 3
Fig. 3
miR-195-5p is a direct target of and negatively regulated by circ_0038718. (A) 21 DE_miRNAs obtained from the GSE126093 Series Matrix File; (B) 12 down-regulated DE_miRNAs were intersected with 115 predicted target genes of circ_0038718; (C) Relative expression of miR-195-5p in GSE126093 Series Matrix File. Blue and red boxes stand for the normal and tumor groups, respectively; (D) Predicted binding site between miR-195-5p and circ_0038718; (E) qRT-PCR was conducted to test the expression of circ_0038718, U6 and GAPDH in cytoplasm and nucleus after nucleocytoplasmic separation of HT-29 and SW480 cells; (F-G) Dual-luciferase reporter assay and RIP experiment were performed to verify the targeting relationship between miR-195-5p and circ_0038718; (H) qRT-PCR was used to evaluate the effect of circ_0038718 over-expression on miR-195-5p; (I) The expression of miR-195-5p in colorectal cancer tissue and adjacent tissue, respectively; (J) The correlation between circ_0038718 and miR-195-5p expression level. * p < 0.05
Fig. 4
Fig. 4
Up-regulation of miR-195-5p can reduce the promoting effect of circ_0038718 on CC cell proliferation, migration and invasion. (A) qRT-PCR was performed to detect miR-195-5p expression in all groups; CC cell viability and proliferative ability were assessed via (B) MTT assay; (C-D) Transwell assay was conducted to evaluate CC cell migratory and invasive capacities (100×). * p < 0.05
Fig. 5
Fig. 5
miR-195-5p regulates Wnt/β-catenin signaling pathway by targeting Axin2. (A) Volcano plot of 415 DE_mRNAs in the GEO database (Red and green dots represent up-regulated and down-regulated genes, respectively); (B) Venn diagram of up-regulated DE_mRNAs in the GEO database and the predicted target mRNAs of miR-195-5p; (C) Relative expression of Axin2 in the GEO database (Blue and red boxes represent normal and tumor group, respectively); (D) The expression level of Axin2 in colorectal cancer tissue and adjaceent tissue; (E) The correlation between Axin2 and miR-195-5p expression level; (F) The correlation between Axin2 and circ_0038718 expression level; (G) Putative binding sites between miR-195-5p and Axin2; (H) Dual-luciferase reporter assay was performed to detect the targeting relationship between miR-195-5p and Axin2; (I) qRT-PCR was performed to assess the effect of over-expressing miR-195-5p on Axin2 mRNA; (J) Western blot was conducted to evaluate the effect of miR-195-5p over-expression on the protein expression of Axin, β-catenin, c-Myc and cyclin D1; (K) qRT-PCR was performed to assess the effect of sh-Axin2 knock down. * p < 0.05
Fig. 6
Fig. 6
circ_0038718 activates Wnt/β-catenin signaling pathway via the circ_0038718/miR-195-5p/Axin2 axis. (A) qRT-PCR was conducted to detect the expression of circ_0038718, miR-195-5p and Axin2 in each group; (B) Western blot was performed to determine the protein expression of Axin2 and the key proteins of the Wnt/β-catenin signaling pathway; CC cell viability and proliferative ability were assessed via (C) MTT assay; (D-E) Transwell assay was conducted to evaluate CC cell migratory and invasive capacities (100×). * p < 0.05
Fig. 7
Fig. 7
circ_0038718 silencing reduces CC cell tumorigenesis in vivo. (A) Tumor cell tumorigenesis of nude mice in all groups was identified; (B) Average tumor weight of nude mice after 5 weeks; (C) Tumor volume of nude mice in all groups for 5 weeks; (D) qRT-PCR was performed to detect the expression of circ_0038718, miR-195-5p and Axin2 in tumor tissue of nude mice; (E) Immunohistochemistry was conducted to assess the expression of Axin2, β-catenin, c-Myc and cyclin D1 in tumor tissue (400×). * p < 0.05

Similar articles

Cited by

References

    1. Chen S, et al. H19 overexpression induces resistance to 1,25(OH)2D3 by targeting VDR through miR-675-5p in Colon Cancer cells. Neoplasia. 2017;19:226–236. doi: 10.1016/j.neo.2016.10.007. - DOI - PMC - PubMed
    1. Zheng R, Zeng H, Zhang S, Chen W. Estimates of cancer incidence and mortality in China, 2013. Chin J Cancer. 2017;36:66. doi: 10.1186/s40880-017-0234-3. - DOI - PMC - PubMed
    1. Benson AB, 3rd, et al. Colon Cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2017;15:370–398. doi: 10.6004/jnccn.2017.0036. - DOI - PubMed
    1. Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008;134:1296–1310. doi: 10.1053/j.gastro.2008.02.098. - DOI - PMC - PubMed
    1. Lordick F, Mossner J. Current standard diagnosis and treatment of Colon Cancer. Dtsch Med Wochenschr. 2017;142:487–490. doi: 10.1055/s-0042-123913. - DOI - PubMed

LinkOut - more resources